SIGN releases leg ulcer advice for Scotland
By Amit Katwala, 02 September 2010
SIGN has issued an updated guideline on the assessment and treatment of venous leg ulcers for patients in Scotland.
The SIGN guideline recommends the use of pentoxyifylline 400mg three times daily for up to six months to improve healing in patients with chronic venous leg ulcers.
It advises that patients should be treated using simple, non-adherent dressings and high compression, multi-component bandaging.
The new guideline suggests considering patch-testing in leg ulcer patients with dermatitis/eczema.
The national clinical guideline replaces previous advice on venous leg ulcers, SIGN 26, published in 1998.
Recurrence of venous leg ulcers in healed patients can be prevented by below-knee graduated compression hosiery.
The guidance says specialist leg ulcer clinics are the optimal choice for treatment in the community.
Further Reading
- Related Drug Categories
- Leg ulcers, pressure sores
Additional Information
Latest jobs Jobs web feed
- Full time GP partner - Isle of Man Laxey and Village Walk Health Centres Competitive, Isle of Man
- Salaried GP Dr K.T. Tattum FRCGP Competitive, Stockton Brook, Stoke-on-Trent, Staffordshire
- General Practitioner x 2 for MOD, RAF Leuchars, Fife MMP Competitive hourly rates offered, East Coast of Scotland
- General Practitioner for Gamecock Barracks, Nuneaton MMP Competitive hourly rates, West Midlands
- GP for MOD, RAF Waddington, Lincs MMP Competitive hourly rates offered, Lincoln
- Locum GP for central east London Surgey HealthCare&Locum Recruitment Ltd Negotiable, Central london
Most read
- NHS reforms: Interactive Health Bill timeline
- Exclusive: 'Stop the mudslinging on pensions' says BMA chairman
- Royal colleges step up Health Bill opposition
- Male GPs more likely to experience burnout than female colleagues
- GPC warns of 'target culture' as GP commissioning framework revealed
- Vaccinate teenagers against meningitis, say DH advisers
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
